PubRank

P J Lefebvre

Author PubWeight™ 61.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001 2.11
2 Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992 1.62
3 Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000 1.45
4 Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia 1977 1.42
5 Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers. Diabetologia 1972 1.15
6 Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care 1991 1.12
7 Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med 1970 0.98
8 Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab 1994 0.95
9 Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes 1974 0.92
10 Plasma glucagon levels in normal women during pregnancy. Diabetologia 1975 0.90
11 Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat. Am J Physiol 1975 0.89
12 Glucagon and diabetes: a reappraisal. Diabetologia 1979 0.88
13 Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism 1975 0.88
14 Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol 1989 0.88
15 Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate. N Engl J Med 1976 0.88
16 Insulin sensitivity, clearance and release in kininogen-deficient rats. Exp Physiol 1999 0.87
17 Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology 1978 0.87
18 Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism 1974 0.86
19 Biological properties of a transplantable islet-cell tumor of the golden hamster. 3. Electron microscopic studies. Diabetes 1968 0.86
20 The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabete Metab 1988 0.86
21 Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) 1991 0.84
22 Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals. Diabetes 1967 0.84
23 Muscular exercise and pancreatic function in rats. Isr J Med Sci 1972 0.83
24 Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs. Metabolism 1976 0.83
25 Fate of exogenous glucose during exercise of different intensities in humans. J Appl Physiol Respir Environ Exerc Physiol 1982 0.83
26 Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia 1979 0.82
27 Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes 1984 0.82
28 Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog. Biochem Pharmacol 1973 0.82
29 [Stimulation by carbamylcholine of dog gastric-glucagon release (author's transl) (proceedings)]. Ann Endocrinol (Paris) 1979 0.82
30 Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab 1998 0.82
31 Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabete Metab 1995 0.81
32 Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric 1999 0.80
33 Metabolic adaptation to prolonged exercise in severely obese subjects. Int J Obes 1983 0.80
34 Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis. Eur J Clin Invest 1976 0.80
35 Insulin oscillations per se do not affect glucose turnover parameters in normal man. J Clin Endocrinol Metab 1986 0.80
36 Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes. Diabetes Metab Res Rev 2001 0.80
37 Independance of glucagon and insulin handling by the isolated perfused dog kidney. Diabetologia 1976 0.80
38 Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects. Int J Obes 1982 0.79
39 Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus 1993 0.79
40 [Bronchial reactivity in diabetic patients]. Rev Mal Respir 1997 0.79
41 Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia 1969 0.79
42 Effect of L8027, a new potent inhibitor of prostaglandin biosynthesis, on the metabolism and response to glucagon of rat adipose tissue. Biochem Pharmacol 1974 0.78
43 Influence of metformin on arginine-induced glucagon secretion in human diabetes. Diabete Metab 1975 0.78
44 Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach. Gut 1978 0.78
45 Inhibition by somatostatin of carbamylcholine-induced gastrin and glucagon release from the isolated perfused canine stomach. Gut 1981 0.78
46 Pharmacological treatment of the obese diabetic patient. Diabete Metab 1994 0.78
47 Pharmacological compounds affecting plasma glucagon levels in rats. Biochem Pharmacol 1976 0.78
48 Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats. Br J Pharmacol 2001 0.78
49 Pituitary-testicular axis in diabetic men with and without sexual impotence. Diabete Metab 1978 0.78
50 Effect of ouabain on insulin secretion in the anesthetized dog. Biochem Pharmacol 1972 0.78
51 Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn Ther 1968 0.78
52 Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets. Diabetologia 1978 0.77
53 Availability of glucose given orally during exercise. J Appl Physiol Respir Environ Exerc Physiol 1984 0.77
54 Historical and methodological aspects of computer-assisted medical history-taking. Med Inform (Lond) 1986 0.77
55 Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. Am J Physiol 1987 0.77
56 The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people. J Clin Endocrinol Metab 1996 0.77
57 Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM. Diabetes Care 1994 0.77
58 Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol 1990 0.77
59 [Advantages of pulsatile administration of human insulin on endogenous pancreatic secretion in the normal subject and in type 1 diabetics]. Ann Med Interne (Paris) 1988 0.77
60 Influence of elevated plasma free fatty acids on the glucagon response to hypoglycemia in normal and in pregnant women. Metabolism 1978 0.77
61 The breakfast tolerance test: a return to physiology. Diabete Metab 1976 0.77
62 Effect of physical training on utilization of a glucose load given orally during exercise. Am J Physiol 1984 0.77
63 Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics. Eur J Clin Pharmacol 1984 0.76
64 Cardiovascular risk factors in a sample of a rural Belgian population: the Bellux MONICA Study. Acta Med Scand Suppl 1988 0.76
65 Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon. Horm Metab Res 1976 0.76
66 [Cardiovascular prevention: could the polypill reduce the risk of clinical inertia and poor compliance?]. Rev Med Liege 2010 0.76
67 Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man. Eur J Clin Invest 1994 0.76
68 Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics. Diabete Metab 1980 0.76
69 [Diabetes in the Belgian province of Luxembourg: frequency, importance of the oral glucose tolerance test and a modestly increased fasting blood glucose]. Diabete Metab 1991 0.76
70 Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. Eur J Clin Pharmacol 1984 0.75
71 Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity. Acta Endocrinol (Copenh) 1991 0.75
72 Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months. Diabetologia 1981 0.75
73 Localization of insulinoma by intraoperative ultrasonography. J R Soc Med 1989 0.75
74 Remarkable metabolic availability of oral glucose during long-duration exercise in humans. J Appl Physiol (1985) 1986 0.75
75 Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents. Br J Clin Pharmacol 1979 0.75
76 Effect of somatostatin in the Syrian hamster bearing a transplantable islet-cell tumor. Horm Metab Res 1978 0.75
77 Studies on the hyperglycemic effect of diphenylhydantoin in normal golden hamsters. Horm Metab Res 1976 0.75
78 [Unexpected or deliberate interruption of a continuous subcutaneous insulin infusion: practical advice]. Diabete Metab 1994 0.75
79 [Adaptation to sports by insulin-treated diabetics]. Diabete Metab 1988 0.75
80 Effect of oleic and octanoic acids on glucagon and insulin secretion in vitro. Horm Metab Res 1982 0.75
81 Adipose tissue lipolysis in golden hamsters with chronic hypoglycemia and hyperinsulinemia due to a transplantable islet cell tumor. Horm Metab Res 1970 0.75
82 Metabolic clearance rate of insulin in type 2 diabetic patients treated with combined insulin and sulfonylurea therapy. Rev Esp Fisiol 1994 0.75
83 [Hemoglobin A1c and diabetes control (author's transl)]. Diabete Metab 1979 0.75
84 Glucagon and gastrin release by the isolated perfused dog stomach in response to arginine. Metabolism 1976 0.75
85 [How I evaluate...diabetic nephropathy. First part: micro- and macroalbuminuria]. Rev Med Liege 1998 0.75
86 Effect of phosphate on the arginine-induced insulin release by the isolated perfused rat pancreas. Adv Exp Med Biol 1980 0.75
87 Effect of bicarbonate on the arginine-induced insulin and glucagon secretion in vitro. Horm Metab Res 1981 0.75
88 Lack of systematic metabolic alterations after a one-hour interruption of continuous subcutaneous insulin infusion in type I diabetic patients. Diabetes Care 1986 0.75
89 Effect of osmolality on availability of glucose ingested during prolonged exercise in humans. J Appl Physiol (1985) 1989 0.75
90 Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects. Metabolism 1992 0.75
91 Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide. Diabete Metab 1977 0.75
92 Measurement of insulin sensitivity by the minimal model method using a simplified intravenous glucose tolerance test: validity and reproducibility. Diabete Metab 1995 0.75
93 Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity. J Clin Endocrinol Metab 1988 0.75
94 [How should insulin sensitivity be evaluated in practice?]. Diabete Metab 1995 0.75
95 Plasma C-peptide response to arginine in insulin-dependent diabetic subjects. J Endocrinol Invest 1980 0.75
96 [Lack of benefit from the intermittent administration of insulin in treatment using subcutaneous perfusion pump in type 1 diabetes]. Diabete Metab 1991 0.75
97 Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide, HB419 and HB420, in non insulin-dependent (type 2) diabetes. Int J Clin Pharmacol Ther Toxicol 1987 0.75
98 Endogenous prostaglandins modulate glucagon secretion by isolated guinea-pig islets. Adv Prostaglandin Thromboxane Res 1980 0.75
99 Circadian profiles of blood glucose and plasma free insulin during treatment with semisynthetic and biosynthetic human insulin, and comparison with conventional monocomponent preparations. Eur J Clin Pharmacol 1983 0.75
100 Neurotransmitters and glucagon release from the isolated, perfused canine stomach. Diabetes 1980 0.75
101 Failure of indomethacin to affect arginine-induced C-peptide and glucagon release in insulin-treated diabetics. Major role of residual B cell function in conditioning the magnitude of the blood glucose rise after intravenous arginine. Diabetologia 1981 0.75
102 Plasma insulin in reactive hypoglycemia. Diabetes 1971 0.75
103 Effect of indomethacin on the metabolic and hormonal response to a standardized breakfast in normal subjects. Acta Diabetol Lat 1982 0.75
104 [Clinical cases, a panacea view of medicine: from the simple anecdote to teaching practice]. Rev Med Liege 2009 0.75
105 B-cell response to a standardized breakfast in end-stage renal failure. Acta Diabetol Lat 1985 0.75
106 Gastric-glucagon: physiology and pathology. Adv Exp Med Biol 1978 0.75
107 Immunogenicity of semisynthetic human insulin in man. Long-term comparison with porcine monocomponent insulin. Acta Diabetol Lat 1986 0.75
108 Assessment of insulin resistance in vivo: application to the study of type 2 diabetes. Horm Res 1992 0.75
109 [How to explore...the metabolic syndrome by its new IDF definition]. Rev Med Liege 2006 0.75
110 Effect of oleic acid on arginine-induced glucagon secretion by the isolated perfused rat pancreas. Acta Diabetol Lat 1980 0.75
111 Exhaustion of blood glucose response and enhancement of insulin response after repeated glucagon injections in type-2 diabetes: potentiation by progressive hyperglycemia. Ann Endocrinol (Paris) 1996 0.75
112 [Metabolic consequences of insulin deficiency]. Journ Annu Diabetol Hotel Dieu 1984 0.75
113 Effect of glucose on plasma glucagon and free fatty acids during prolonged exercise. Eur J Appl Physiol Occup Physiol 1978 0.75
114 [Non-insulin-dependent diabetes: from physiopathology to treatment]. Bull Mem Acad R Med Belg 1996 0.75
115 [Perspectives on atypical routes of insulin administration. Oral, rectal, and nasal routes]. Ann Endocrinol (Paris) 1988 0.75
116 Cryptocrine signaling in the thymus network and T cell education to neuroendocrine self-antigens. J Mol Med (Berl) 1995 0.75
117 Relationship between plasma free fatty acid levels and human placental lactogen secretion in late pregnancy. J Clin Endocrinol Metab 1977 0.75
118 [Extrapancreatic glucagon: experimental findings and clinical significance]. Journ Annu Diabetol Hotel Dieu 1978 0.75
119 [A transplantable insuloma of the Syrian hamster Mesocricetus auratus auratus. Review of its properties and of its effects on the host]. Acta Diabetol Lat 1968 0.75
120 Glucagon secretion by the transplantable islet-cell tumor of the Syrian hamster. Horm Metab Res 1976 0.75
121 [How should insulin secretion be evaluated in practice?]. Diabete Metab 1995 0.75
122 [Role of insulin and counter-regulatory hormones in the metabolic changes caused by insulin deprivation in diabetic patients]. Rev Esp Fisiol 1989 0.75
123 Hormonal and metabolic changes induced by elevated plasma free fatty acids in term pregnancy. I. Effect on maternal blood glucose, insulin and human placental lactogen circulating levels. J Clin Endocrinol Metab 1975 0.75
124 Effect of physical training on the oxidation of an oral glucose load at rest: a naturally labeled 13C-glucose study. Diabete Metab 1983 0.75
125 [Beta cells in Type II diabetes: culprit or victim?]. Journ Annu Diabetol Hotel Dieu 1991 0.75
126 [United Kingdom Prospective Diabetes Study (UKPDS): 10 years later]. Rev Med Liege 2008 0.75
127 A role for beta-endorphin in the pathogenesis of human obesity? Horm Metab Res 1991 0.75
128 [Insulin glargine and cancer: a storm in a glass of water?]. Rev Med Liege 2009 0.75
129 Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: a one-year randomized, prospective, comparative trial. Am J Obstet Gynecol 1990 0.75
130 Computer-assisted instruction for diabetics. An original project developed at the University of Liège, Belgium. Diabete Metab 1981 0.75
131 Effect of protein-supplemented fasting on the fuel-hormone response to prolonged exercise in obese subjects. Int J Obes 1983 0.75
132 Insulin, prostaglandin E2 and glucagon release by human tissue incubated in vitro. Influence of indomethacin. Diabete Metab 1981 0.75
133 [Ultimate treatment of type 2 diabetes: intensive insulin therapy or bariatric surgery?]. Journ Annu Diabetol Hotel Dieu 1998 0.75
134 Pancreatic B-cell response to a test-meal in lean and obese diabetic patients: relation to metabolic control. Acta Diabetol Lat 1981 0.75
135 [The glucagonomas (author's transl)]. Diabete Metab 1981 0.75
136 Anti-insulin antibodies and metabolic deterioration after interruption of continuous subcutaneous insulin infusion. Diabetes Care 1987 0.75
137 Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1995 0.75
138 [Postaglandins and pancreatic hormones]. Journ Annu Diabetol Hotel Dieu 1981 0.75
139 [Prostaglandins, insulin secretion and diabetes mellitus]. Diabete Metab 1988 0.75
140 [Magnesium and the regulation of carbohydrate metabolism]. Journ Annu Diabetol Hotel Dieu 1991 0.75
141 Insulin-stimulated glucose disposal is not increased in anorexia nervosa. J Clin Endocrinol Metab 1985 0.75
142 Effect of somatostatin on metabolic and hormonal changes induced by nicotinic acid in insulin-dependent diabetics. Diabetologia 1976 0.75
143 [How to explore insulin sensitivity in man?]. Ann Endocrinol (Paris) 1995 0.75